National Research Corporation NASDAQ:NRC

Founder-led company

National Research stock price today

$16.17
-1.25
-7.23%
Financial Health
0
1
2
3
4
5
6
7
8
9

National Research stock price monthly change

-25.89%
month

National Research stock price quarterly change

-25.89%
quarter

National Research stock price yearly change

-55.74%
year

National Research key metrics

Market Cap
405.19M
Enterprise value
459.35M
P/E
15.26
EV/Sales
3.18
EV/EBITDA
10.60
Price/Sales
2.83
Price/Book
11.94
PEG ratio
1.45
EPS
1.25
Revenue
147.42M
EBITDA
46.29M
Income
30.36M
Revenue Q/Q
-3.18%
Revenue Y/Y
-1.45%
Profit margin
18.79%
Oper. margin
25.91%
Gross margin
57.85%
EBIT margin
25.91%
EBITDA margin
31.4%
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

National Research stock price history

National Research stock forecast

National Research financial statements

National Research Corporation (NASDAQ:NRC): Profit margin
Jun 2023 36.16M 7.27M 20.11%
Sep 2023 37.94M 7.87M 20.76%
Dec 2023 38.00M 8.85M 23.31%
Mar 2024 35.31M 6.35M 18.01%
2.75%
Yield TTM
National Research Corporation (NASDAQ:NRC): Payout ratio
Payout ratio 42.77%
National Research Corporation (NASDAQ:NRC): Dividend Yield
2019 1.91%
2020 0.98%
2021 0.87%
2022 2.25%
2023 3.75%
National Research Corporation (NASDAQ:NRC): Debt to assets
Jun 2023 133627000 55.87M 41.82%
Sep 2023 120136000 62.26M 51.83%
Dec 2023 122437000 73.48M 60.02%
Mar 2024 120911000 83.96M 69.44%
National Research Corporation (NASDAQ:NRC): Cash Flow
Jun 2023 8.83M -4.33M -5.72M
Sep 2023 9.81M -4.47M -24.01M
Dec 2023 11.70M -3.77M -5.11M
Mar 2024 12.03M -4.13M -12.85M

National Research alternative data

National Research Corporation (NASDAQ:NRC): Employee count
Aug 2023 491
Sep 2023 491
Oct 2023 491
Nov 2023 491
Dec 2023 491
Jan 2024 491
Feb 2024 491
Mar 2024 435
Apr 2024 435
May 2024 435
Jun 2024 435
Jul 2024 435

National Research other data

30.56% -13.98%
of NRC is owned by hedge funds
7.70M -3.60M
shares is hold by hedge funds

National Research Corporation (NASDAQ:NRC): Insider trades (number of shares)
Period Buy Sel
Apr 2023 0 7588
May 2023 0 32416
Jun 2023 0 125398
Oct 2023 0 1601
Nov 2023 0 1187
Dec 2023 0 83517
Jan 2024 0 693078
Mar 2024 0 598653
Transaction Date Insider Security Shares Price per share Total value Source
Option
NUNNELLY JOHN N director
Common Stock 9,259 $14.95 $138,422
Option
NUNNELLY JOHN N director
Director Stock Option (Right to Buy) 9,259 $14.95 $138,422
Sale
COMMON PROPERTY TRUST 10 percent owner
Common Stock 598,653 $40.54 $24,269,393
Sale
AMANDLA MK TRUST 10 percent owner
Common Stock 2,614 $40.2 $105,093
Sale
AMANDLA MK TRUST 10 percent owner
Common Stock 4,600 $41.22 $189,617
Sale
AMANDLA MK TRUST 10 percent owner
Common Stock 120,139 $41.78 $5,018,807
Sale
COMMON PROPERTY TRUST 10 percent owner
Common Stock 364,625 $41.53 $15,142,876
Option
HAYS MICHAEL D. director, officer: CEO & Presid..
Common Stock 2,904 $18.8 $54,595
Option
HAYS MICHAEL D. director, officer: CEO & Presid..
Employee Stock Option (right to buy) 2,904 $18.8 $54,595
Sale
AMANDLA MK TRUST 10 percent owner
Common Stock 180,500 $40.21 $7,257,905
Insider Compensation
Ms. Jona S. Raasch (1959) Chief Operating Officer $453,910
Mr. Kevin R. Karas CPA, CPA (1958) Senior Vice President of Fin., Chief Financial Officer, Treasurer & Sec.
$431,520
Ms. Helen L. Hrdy (1965) Chief Growth Officer $430,060
Mr. Michael D. Hays (1955) Founder, Chief Executive Officer, Pres & Director $194,250
Wednesday, 27 November 2024
zacks.com
Wednesday, 20 November 2024
businesswire.com
Friday, 25 October 2024
businesswire.com
Tuesday, 6 August 2024
businesswire.com
Monday, 22 July 2024
globenewswire.com
Monday, 8 July 2024
benzinga.com
Monday, 20 May 2024
https://www.prnewswire.com
Saturday, 11 May 2024
Seeking Alpha
Thursday, 18 April 2024
Business Wire
Thursday, 1 February 2024
Business Wire
Wednesday, 8 November 2023
Seeking Alpha
Tuesday, 24 October 2023
GlobeNewsWire
Saturday, 5 August 2023
Seeking Alpha
Monday, 22 May 2023
Seeking Alpha
Tuesday, 18 April 2023
GlobeNewsWire
Wednesday, 15 February 2023
Seeking Alpha
Monday, 30 January 2023
GlobeNewsWire
Wednesday, 4 January 2023
InvestorPlace
Saturday, 5 November 2022
Seeking Alpha
Thursday, 3 November 2022
InvestorPlace
Wednesday, 19 October 2022
GlobeNewsWire
Sunday, 18 September 2022
Seeking Alpha
Saturday, 3 September 2022
The Motley Fool
Saturday, 6 August 2022
Seeking Alpha
Tuesday, 19 July 2022
GlobeNewsWire
Tuesday, 17 May 2022
Seeking Alpha
Saturday, 7 May 2022
Seeking Alpha
Tuesday, 19 April 2022
GlobeNewsWire
Friday, 1 April 2022
The Motley Fool
Wednesday, 9 February 2022
Seeking Alpha
  • What's the price of National Research stock today?

    One share of National Research stock can currently be purchased for approximately $16.17.

  • When is National Research's next earnings date?

    Unfortunately, National Research's (NRC) next earnings date is currently unknown.

  • Does National Research pay dividends?

    Yes, National Research pays dividends and its trailing 12-month yield is 2.75% with 43% payout ratio. The last National Research stock dividend of $0.12 was paid on 14 Jan 2022.

  • How much money does National Research make?

    National Research has a market capitalization of 405.19M and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 1.97% to 148.58M US dollars.

  • What is National Research's stock symbol?

    National Research Corporation is traded on the NASDAQ under the ticker symbol "NRC".

  • What is National Research's primary industry?

    Company operates in the Healthcare sector and Medical - Healthcare Information Services industry.

  • How do i buy shares of National Research?

    Shares of National Research can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are National Research's key executives?

    National Research's management team includes the following people:

    • Ms. Jona S. Raasch Chief Operating Officer(age: 66, pay: $453,910)
    • Mr. Kevin R. Karas CPA, CPA Senior Vice President of Fin., Chief Financial Officer, Treasurer & Sec.(age: 67, pay: $431,520)
    • Ms. Helen L. Hrdy Chief Growth Officer(age: 60, pay: $430,060)
    • Mr. Michael D. Hays Founder, Chief Executive Officer, Pres & Director(age: 70, pay: $194,250)
  • Is National Research founder-led company?

    Yes, National Research is a company led by its founder Mr. Michael D. Hays.

  • How many employees does National Research have?

    As Jul 2024, National Research employs 435 workers.

  • When National Research went public?

    National Research Corporation is publicly traded company for more then 12 years since IPO on 23 May 2013.

  • What is National Research's official website?

    The official website for National Research is nrchealth.com.

  • Where are National Research's headquarters?

    National Research is headquartered at 1245 Q Street, Lincoln, NE.

  • How can i contact National Research?

    National Research's mailing address is 1245 Q Street, Lincoln, NE and company can be reached via phone at +40 24752525.

National Research company profile:

National Research Corporation

nrchealth.com
Exchange:

NASDAQ

Full time employees:

435

Industry:

Medical - Healthcare Information Services

Sector:

Healthcare

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience in the United States and Canada. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, health risk assessments, employee engagement, reputation management, and brand loyalty. The company also offers market insights solutions that allow the tracking of awareness, perception, and consistency of healthcare brands; assessment of competitive differentiators; and enhanced segmentation tools to evaluate needs, wants, and behaviors of communities through real-time competitive assessments and enhanced segmentation tools. In addition, it provides experience solutions, such as patient and resident experience, workforce engagement, health risk assessments, transitions, and improvement tools. Further, the company offers health risk assessment solutions that enable clients to segment populations and manage care for those who are most at risk, engage individuals, enhance preventative care, and manage wellness programs; and transitions solutions, which enable organizations to identify and manage high-risk patients to reduce readmissions, enhance patient satisfaction and support safe care transitions. Additionally, it provides transparency solutions that allow healthcare organizations to share picture of their organization and ensure content informs in consumer decision-making; and governance solutions for not-for-profit hospital and health system boards of directors, executives, and physician leadership. The company serves integrated health systems, post-acute providers, and payer organizations. National Research Corporation was founded in 1981 and is headquartered in Lincoln, Nebraska.

1245 Q Street
Lincoln, NE 68508

CIK: 0000070487
ISIN: US6373722023
CUSIP: 637372202